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Epidemiologic evaluation found that influenza-associated pedi-
atric hospitalization and mortality rates were higher during the 
2009–2010 influenza season than in other recent influenza sea-
sons, mostly due to infection with influenza A (H1N1) virus.1 
Public health officials identified children and adolescents six-
months to 24 years old as one of five priority groups for receiv-
ing doses of 2009 influenza A (H1N1) monovalent vaccination 
when they first became available in the US.2 Examination of 
vaccination behavior in the setting of the extensive public health 
response to pandemic 2009–2010 H1N1 influenza provides use-
ful information for understanding how people might respond 
during future influenza pandemics.
Most research on intentions to get 2009 H1N1 vaccine, use of 
the vaccine or other H1N1 protective behaviors has focused on 
healthcare workers or other adult populations.3-7 Few studies have 
examined these topics among children or adolescents. Of the lit-
tle research done, results indicated that about 60% of parents 
intended to get their children 2009 H1N1 vaccine,8,9 though a 
national assessment found only 28% of children ages 5–18 years 
had actually been vaccinated.10
Correlates of vaccination and potential explanations for lower 
than expected 2009 H1N1 vaccine uptake among adolescents 
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results: overall, 22% (221/944) of mothers indicated their daughters had received 2009 H1N1 vaccine. H1N1 vaccina-
tion was higher among daughters who had received 2009 seasonal influenza vaccine (49% vs. 11%, or = 7.00, 95% CI: 
4.18–11.73) or whose mothers expressed higher trust in their daughters’ healthcare providers (26% vs. 11%, or = 2.28, 
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ing December 2009 using an online survey.
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have not been well examined. For example, it is not clear how 
many additional parents wanted the vaccine for their children 
but were unable to get it. In past influenza seasons with a limited 
supply of vaccine available, many people attempted to get vac-
cinated but were not successful in doing so.11 We aimed to char-
acterize correlates of 2009 H1N1 vaccination among adolescent 
females ages 11–14 years in the US and examine accessibility of 
the vaccine to their parents.
In December 2009, we interviewed a national sample of 
mothers of adolescent females ages 11–14 years who were mem-
bers of an existing national panel of US households maintained 
by an online survey company.12 The survey company composed 
the panel using a dual frame approach combining list-assisted, 
random-digit dialing and address-based sample frames, which 
provided a probability-based sample of US households.13 
Households containing at least one panel member receive free 
Internet access in exchange for panel members completing mul-
tiple Internet-based surveys each month. In households with 
existing computer and Internet access, panel members accumu-
late points for completing surveys that can later be redeemed 
for small cash payments. Our survey focused primarily on 
mother-daughter communication about human papillomavirus 
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daughters’ healthcare providers were also more likely to report 
H1N1 vaccination among their daughters (26% vs. 11%, OR = 
2.28, 95% CI: 1.10–4.73).
Among mothers whose daughters had not been vaccinated, 
20% (150/723) indicated they wanted to get their daughters 
2009 H1N1 vaccine but were unable to (Table 2). In adjusted 
analyses, mothers whose daughters had received 2009 seasonal 
influenza vaccine were more likely to report they wanted to get 
their daughters H1N1 vaccine but were unable to (34% vs. 17%, 
OR = 2.75, 95% CI: 1.48–5.11). Mothers from the northeast 
region of the US, were less likely than mothers from the west to 
report they wanted to get their daughters H1N1 vaccine but were 
unable to (15% vs. 27%, OR = 0.46, 95% CI: 0.21–0.99).
Less than a quarter of mothers in this national sample indi-
cated their adolescent daughters (ages 11–14 years) had received 
2009 H1N1 vaccine by December 2009, an estimate similar to 
another national study.10 A novel finding is that 20% of mothers 
of unvaccinated daughters indicated they wanted to get them the 
vaccine but were unable to, highlighting the potential difficulty 
some individuals encountered in obtaining 2009 H1N1 vaccine 
during the fall of 2009. In other words, vaccination levels might 
have almost doubled if 2009 H1N1 vaccine had been more read-
ily available during this time. These parents may have had later 
opportunities to vaccinate their children, as 2009 H1N1 vaccine 
became more readily available by early 2010. However, even if 
these mothers had all been able to obtain 2009 H1N1 vaccine 
for their daughters, vaccination levels would have still been lower 
than expected based on previous estimates of parents’ intent to 
get their children H1N1 vaccine (about 60%).8,9
Daughters’ receipt of seasonal influenza vaccine was a strong 
correlate of 2009 H1N1 vaccination, comparable to findings 
among adults.6 Similar to past influenza seasons,17 less than 30% 
of daughters had received seasonal influenza vaccine, despite rec-
ommendations that children and adolescents should receive an 
annual influenza vaccine.18 Furthermore, less than half of daugh-
ters who received 2009 seasonal influenza vaccine also received 
2009 H1N1 vaccine, though some parents may not have been 
able to get their daughters 2009 H1N1 vaccine due to vaccine 
unavailability. Taken together, our results suggest that seasonal 
influenza vaccination continues to be suboptimal among adoles-
cents and missed opportunities for H1N1 vaccination occurred 
during provider visits for seasonal influenza vaccine. At the time, 
inactivated seasonal and H1N1 vaccines could be given during 
the same visit if different anatomic sites were used.2 While the 
2010–2011 seasonal influenza vaccine includes the 2009 H1N1 
virus,19 concomitant administration is a vaccine delivery strategy 
that may help maximize vaccine coverage in future situations 
where multiple influenza vaccines are recommended.
Mothers whose daughters had received seasonal influenza 
vaccine were also more likely to report they wanted to get their 
daughters 2009 H1N1 vaccine but were unable to. This find-
ing is likely due to these mothers seeking H1N1 vaccination for 
their daughters more frequently than mothers whose daughters 
had not received seasonal influenza vaccine, possibly at the same 
time. Although H1N1 vaccination levels were low in general, it 
is encouraging that vaccination or accessibility of the vaccine to 
(HPV) vaccine, but it also examined 2009 H1N1 vaccination, 
the focus of this report.
The survey company invited 1,681 mothers to complete our 
cross-sectional, online survey. Among those mothers, 1,009 
responded to the invitation and had a daughter ages 11–14 years, 
making them eligible to participate in the study (511 never 
responded to the invitation and 161 responded but did not have a 
daughter ages 11–14 years). A total of 951 mothers (response rate 
= 66%),14 provided informed consent and completed a survey. 
Compared with participants, non-participants were less likely to 
have a college degree. Participants and non-participants did not 
differ on other demographic factors. As seven mothers did not 
provide H1N1 vaccination information about their daughters, we 
report data from 944 mothers. The Institutional Review Board at 
the University of North Carolina approved the study.
The survey item assessing 2009 H1N1 vaccination read, 
“This year, you may have heard about a type of the flu called 
H1N1, also known as Swine Flu. This is not the seasonal flu. 
Has [daughter’s name] received H1N1 flu vaccine?” Mothers 
who indicated their daughters had not received H1N1 vaccine 
were then asked, “Did you want to get [daughter’s name] H1N1 
flu vaccine but were unable to?” We included this item to exam-
ine accessibility of 2009 H1N1 vaccine to parents. The survey 
assessed seasonal influenza vaccination using the item, “Each fall 
a seasonal influenza or flu vaccine becomes available. It can be 
given as a shot injected into the arm or as a mist that is sprayed 
in the nose (also called FluMist). This is not the H1N1 or Swine 
Flu vaccine. Has [daughter’s name] received a seasonal flu vaccine 
this flu season (since this summer)?” The survey also collected 
information on various characteristics of the mothers, daughters 
and their households (Table 1). We defined “urban” as living in a 
metropolitan statistical area (MSA) and “rural” as living outside 
of an MSA.15
We used logistic regression to identify correlates of 2009 
H1N1 vaccination, entering all variables associated (p < 0.10) in 
bivariate analyses into a multivariate model. The same method 
was used to identify correlates of accessibility of 2009 H1N1 vac-
cine to parents. Analyses using Intercooled Stata Version 10.1 
(College Station, TX) applied sampling weights16 to account for 
the study design. Percentages are weighted and frequencies are 
unweighted.
Most mothers were age 40 or older (57%), non-Hispanic 
white (63%), married or living with a partner (89%), did not 
have a college degree (70%), reported a household income of 
at least $60,000 (52%) and lived in urban areas (82%). The 
daughters’ mean age was 12.5 years (standard deviation [SD] 
= 1.2). Although most mothers indicated their daughters had 
health insurance (93%) and a preventive care visit in the last year 
(74%), only 28% reported their daughters had received 2009 sea-
sonal influenza vaccine.
Overall, 22% (221/944) of mothers indicated their daughters 
had received 2009 H1N1 vaccine (Table 1). In adjusted analy-
ses, H1N1 vaccination was higher among daughters who had 
received 2009 seasonal influenza vaccine than those who had not 
(49% vs. 11%, odds ratio [OR] = 7.00, 95% confidence interval 
[CI]: 4.18–11.73). Mothers who expressed higher trust in their 
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Table 1. 2009 H1N1 influenza vaccination among adolescent females in the US (n = 944)
No. mothers reporting daughters 
had received 2009 H1N1 vaccine/





Total 221/944 (22) -- --
Daughter Characteristics
Age (Years)
     11 68/252 (18) ref. --
     12 38/195 (20) 1.08 (0.55–2.15) --
     13 62/241 (27) 1.62 (0.91–2.87) --
     14 53/256 (25) 1.43 (0.77–2.68) --
Type of Healthcare Provider Daughter Sees Most Often
     other 60/339 (20) ref. --
     pediatrician 161/605 (24) 1.24 (0.73–2.10) --
Had a Preventive Care Visit in Last Year
     No 41/259 (15) ref. ref.
     Yes 180/685 (25) 1.92 (1.13–3.26)* 1.18 (0.66–2.13)
Health Insurance Coverage
     No 8/42 (20) ref. --
     Yes 213/902 (22) 1.13 (0.34–3.74) --
Received Seasonal Influenza Vaccine (since August 2009)
     No 84/665 (11) ref. ref.
     Yes 137/279 (49) 7.59 (4.57–12.61)** 7.00 (4.18–11.73)**
Mother Characteristics
Age (Years)
     <40 60/302 (22) 1.14 (0.59–2.18) --
     40–49 126/509 (24) 1.28 (0.72–2.27) --
     50+ 35/133 (19) ref. --
Race/Ethnicity
     White, Non-Hispanic 173/714 (21) ref. --
     African American, Non-Hispanic 15/86 (26) 1.34 (0.61–2.94) --
     other race, Non-Hispanic 16/59 (23) 1.17 (0.48–2.84) --
     Hispanic 17/85 (24) 1.22 (0.50–2.95) --
Marital Status
     Divorced, Widowed, Separated, Never 
     Married
31/147 (20) ref. --
     Married or Living with partner 190/797 (23) 1.14 (0.58–2.24) --
Education Level
     No College Degree 111/486 (23) ref. --
     College Degree 110/458 (22) 0.95 (0.63–1.42) --
Satisfied with Quality of Healthcare Daughter Receives
     Very Dissatisfied/Somewhat Dissatisfied/ 
     Neutral
12/65 (11) ref. ref.
     Very Satisfied/Somewhat Satisfied 209/879 (23) 2.57 (1.10–5.99)* 0.93 (0.39–2.23)
Trusts Daughter’s Healthcare Provider So Much that Always Try To Follow His or Her Advice
     Strongly Disagree/Somewhat Disagree/ 
     Neutral
33/182 (11) ref. ref.
     Strongly Agree/Somewhat Agree 188/762 (26) 2.87 (1.46–5.63)* 2.28 (1.10–4.73)*
Household Characteristics
Household Income
     <$60,000 75/343 (24) ref. --
Note: the adjusted model did not include variables with dashes (--). or, odds ratio; CI, confidence interval; ref., referent group. *p < 0.05, **p < 0.001.
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vaccine availability likely explains a substantial portion of the 
shortfall. Incorporation of the 2009 H1N1 virus into the 2010–
2011 seasonal influenza vaccine will almost certainly increase 
protection against H1N1 during the upcoming influenza season. 
However, as new vaccine-preventable agents emerge, it will be 
important to understand past reasons for low vaccine uptake to 
anticipate future public health challenges.
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parents did not differ by race, socioeconomic status or health 
insurance status.
Healthcare providers appear to play a central role in H1N1 
vaccination, as mothers’ trust of their daughters’ healthcare 
providers was correlated with vaccination. Parents’ trust in the 
healthcare system has been shown to be an influential determi-
nant of childhood vaccination.20 This factor may become increas-
ingly important as controversies surrounding childhood and 
adolescent vaccination persist.
Study strengths include data on a rapidly emergent public 
health threat from a national sample, as well as focusing on one of 
the five priority groups for 2009 H1N1 vaccination. Study limi-
tations include data collection occurring relatively early in the 
influenza season and reliance on mothers’ reports of vaccination, 
though parents tend to accurately recall their children’s influenza 
vaccination status.21 We did not collect information regarding 
why some mothers were unsuccessful in getting their daughters 
2009 H1N1 vaccine. Our sample included only mothers of ado-
lescent females ages 11–14 years, and the generalizability of our 
findings is not known.
Our results provide important insights into 2009 H1N1 vac-
cine coverage among adolescents in the US. If previous estimates 
of parents’ vaccination intentions are applied to our study,8,9 it 
appears that only about one in three parents who intended to 
get their children 2009 H1N1 vaccine actually did so. Lack of 
Table 1 continued. 2009 H1N1 influenza vaccination among adolescent females in the U.S. (n = 944)
     ≥$60,000 146/601 (21) 0.86 (0.53–1.38) --
Urbanicity
     rural 28/132 (26) ref. --
     Urban 193/812 (21) 0.77 (0.39–1.54) --
Region of Residence
     West 43/229 (17) ref. --
     South 61/269 (26) 1.70 (0.86–3.37) --
     Midwest 72/290 (21) 1.34 (0.71–2.53) --
     Northeast 45/156 (23) 1.51 (0.78–2.95) --
Note: the adjusted model did not include variables with dashes (--). or, odds ratio, CI, confidence interval, ref., referent group. *p < 0.05, **p < 0.001.
Table 2. Accessibility of 2009 H1N1 vaccine to parents of unvaccinated daughters in the US (n = 723)
No. mothers reporting they wanted to 
get their daughters H1N1 vaccine but 






Total 150/723 (20) -- --
Daughter Characteristics
Age (Years)
     11 44/184 (24) ref. --
     12 30/157 (19) 0.77 (0.34–1.76) --
     13 32/179 (15) 0.58 (0.28–1.22) --
     14 44/203 (20) 0.82 (0.39–1.75) --
Type of Healthcare Provider Daughter Sees Most Often
Note: the adjusted model did not include variables with dashes (--). or, odds ratio; CI, confidence interval; ref., referent group. *p < 0.05, †p < 0.10.
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Table 2. Accessibility of 2009 H1N1 vaccine to parents of unvaccinated daughters in the US (n = 723)
     other 51/279 (21) ref. --
     pediatrician 99/444 (20) 0.94 (0.52–1.68) --
Had a Preventive Care Visit in Last Year
     No 40/218 (24) ref. --
     Yes 110/505 (19) 0.74 (0.39–1.41) --
Health Insurance Coverage
     No 9/34 (12) ref. --
     Yes 141/689 (21) 1.85 (0.67–5.11) --
Received Seasonal Influenza Vaccine (since August 2009)
     No 91/581 (17) ref. ref.
     Yes 59/142 (34) 2.59 (1.37–4.87)* 2.75 (1.48–5.11)*
Mother Characteristics
Age (Years)
     <40 41/242 (17) 0.56 (0.23–1.37) --
     40–49 86/383 (21) 0.70 (0.30–1.60) --
     50+ 23/98 (27) ref. --
Race/Ethnicity
     White, Non-Hispanic 108/541 (18) ref. --
     African American, Non-Hispanic 14/71 (24) 1.41 (0.60–3.28) --
     other race, Non-Hispanic 12/43 (21) 1.17 (0.43–3.20) --
     Hispanic 16/68 (24) 1.40 (0.53–3.70) --
Marital Status
     Divorced, Widowed, Separated, Never Married 26/116 (26) ref. --
     Married or Living with partner 124/607 (19) 0.65 (0.31–1.36) --
Education Level
     No College Degree 77/375 (20) ref. --
     College Degree 73/348 (20) 1.03 (0.62–1.70) --
Satisfied with Quality of Healthcare Daughter Receives
     Very Dissatisfied/Somewhat Dissatisfied/ 
     Neutral
10/53 (35) ref. --
     Very Satisfied/Somewhat Satisfied 140/670 (18) 0.43 (0.15–1.24) --
Trusts Daughter’s Healthcare Provider So Much that Always Try To Follow His or Her Advice
     Strongly Disagree/Somewhat Disagree/Neutral 24/149 (18) ref. --
     Strongly Agree/Somewhat Agree 126/574 (21) 1.20 (0.56–2.56) --
Household Characteristics
Household Income
     <$60,000 48/268 (22) ref. --
     ≥$60,000 102/455 (18) 0.77 (0.44–1.34) --
Urbanicity
     rural 15/104 (13) ref. --
     Urban 135/619 (21) 1.81 (0.86–3.77) --
Region of Residence
     West 48/186 (27) ref. ref.
     South 34/208 (17) 0.56 (0.27–1.18) 0.50 (0.23–1.09)†
     Midwest 44/218 (20) 0.66 (0.31–1.41) 0.63 (0.29–1.33)
     Northeast 24/111 (15) 0.48 (0.23–1.02)† 0.46 (0.21–0.99)*
Note: the adjusted model did not include variables with dashes (--). or, odds ratio; CI, confidence interval; ref., referent group. *p < 0.05, †p < 0.10.
(continued)
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